This inventor holds 2 USPTO granted patents. Top assignee: Transgene S.a.. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: Sylvie Campourcy: Innovator in Orthopoxvirus Research
Introduction
Sylvie Campourcy is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of virology, particularly in the production and purification of Orthopoxvirus. With a total of 2 patents to her name, her work is paving the way for advancements in medical treatments.
Latest Patents
One of her latest patents focuses on a method for producing and purifying a wild type, attenuated, and/or recombinant Orthopoxvirus. This invention relates to a purified Orthopoxvirus that can be utilized in pharmaceutical compositions, particularly vaccines aimed at treating and preventing cancer, infectious diseases, and autoimmune disorders. Additionally, the patent discusses the use of an immortalized avian cell line from the Anatidae family, which includes a nucleic acid sequence coding for telomerase reverse transcriptase (TERT), for the production of Orthopoxvirus.
Career Highlights
Sylvie Campourcy is currently associated with Transgene S.A., a company known for its innovative approaches in biotechnology. Her work at Transgene has been instrumental in advancing research in viral therapies and vaccine development.
Collaborations
Throughout her career, Sylvie has collaborated with notable colleagues, including Claude Sene and Yves Cordier. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Sylvie Campourcy's innovative work in Orthopoxvirus research exemplifies her dedication to advancing medical science. Her patents and collaborations reflect her significant impact in the field, making her a key figure in the ongoing fight against diseases.